Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gustafson

Showing results (511-520 of 634) with videos related to

Pageof 64
Sort By:
Journal of Feline Medicine and Surgery|October 30, 2019
Pilot study of side effects and serum and urine concentrations of amoxicillin-clavulanic acid in azotemic and non-azotemic catsKellyi K Benson, Jessica M Quimby, Kristy L Dowers, et al.
Electrophoresis|June 26, 2022
cyc-DEP: Cyclic immunofluorescence profiling of particles collected using dielectrophoresisKyle T Gustafson, Zeynep Sayar, Hillary Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft modelTeresa Troiani, Natalie J Serkova, Daniel L Gustafson, et al.
Annals of Internal Medicine|December 1, 1985
A waterborne outbreak of cryptosporidiosis in normal hostsR G D'Antonio, R E Winn, J P Taylor, et al.
Dalton Transactions (Cambridge, England : 2003)|February 12, 2010
Molecular, electronic structure and spectroscopic properties of MM quadruply bonded units supported by trans-6-carboethoxy-2-carboxylatoazulene ligandsBrian G Alberding, Mikhail V Barybin, Malcolm H Chisholm, et al.
Science (New York, N.Y.)|January 7, 1994
A transforming growth factor beta type I receptor that signals to activate gene expressionC H Bassing, J M Yingling, D J Howe, et al.
American Journal of Clinical Pathology|November 21, 2009
Applying Lean/Toyota production system principles to improve phlebotomy patient satisfaction and workflowStacy E F Melanson, Ellen M Goonan, Margaret M Lobo, et al.
Diabetes|August 6, 2008
Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic diseaseHong Lan, Lizbeth M Hoos, Li Liu, et al.
Investigational New Drugs|November 2, 2006
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patientsThomas W Flaig, Daniel L Gustafson, Lih-Jen Su, et al.
BMC Veterinary Research|June 3, 2014
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumorCharles H C Halsey, Daniel L Gustafson, Barbara J Rose, et al.
Pageof 64

Showing results (511-520 of 634) with videos related to

Sort By:
Pageof 64
Journal of Feline Medicine and Surgery|October 30, 2019
Pilot study of side effects and serum and urine concentrations of amoxicillin-clavulanic acid in azotemic and non-azotemic catsKellyi K Benson, Jessica M Quimby, Kristy L Dowers, et al.
Electrophoresis|June 26, 2022
cyc-DEP: Cyclic immunofluorescence profiling of particles collected using dielectrophoresisKyle T Gustafson, Zeynep Sayar, Hillary Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft modelTeresa Troiani, Natalie J Serkova, Daniel L Gustafson, et al.
Annals of Internal Medicine|December 1, 1985
A waterborne outbreak of cryptosporidiosis in normal hostsR G D'Antonio, R E Winn, J P Taylor, et al.
Dalton Transactions (Cambridge, England : 2003)|February 12, 2010
Molecular, electronic structure and spectroscopic properties of MM quadruply bonded units supported by trans-6-carboethoxy-2-carboxylatoazulene ligandsBrian G Alberding, Mikhail V Barybin, Malcolm H Chisholm, et al.
Science (New York, N.Y.)|January 7, 1994
A transforming growth factor beta type I receptor that signals to activate gene expressionC H Bassing, J M Yingling, D J Howe, et al.
American Journal of Clinical Pathology|November 21, 2009
Applying Lean/Toyota production system principles to improve phlebotomy patient satisfaction and workflowStacy E F Melanson, Ellen M Goonan, Margaret M Lobo, et al.
Diabetes|August 6, 2008
Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic diseaseHong Lan, Lizbeth M Hoos, Li Liu, et al.
Investigational New Drugs|November 2, 2006
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patientsThomas W Flaig, Daniel L Gustafson, Lih-Jen Su, et al.
BMC Veterinary Research|June 3, 2014
Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumorCharles H C Halsey, Daniel L Gustafson, Barbara J Rose, et al.
Pageof 64